Sangamo Therapeutics, Inc. (SGMO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Sangamo Therapeutics, Inc. (SGMO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $30.7M, listed on PNK, employing roughly 127 people, carrying a beta of 1.29 to the broader market. Sangamo Therapeutics, Inc. Led by Alexander D. Macrae Ch.B, public since 2000-04-06.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for SGMO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.